Decrease Implantation Site INFECTION (DISINFECTION I): a Randomized Controlled Trial
Phase 1 Study of Prevention of Cardiac Device Implantation Site Infection
1 other identifier
interventional
352
1 country
1
Brief Summary
Cardiovascular implantable electronic device (CIED) infections have been increasing out of proportion to the number of devices implanted We investigated recent trends and possible causes of the increasing numbers of Cardiovascular implantable electronic device infections.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 12, 2014
CompletedFirst Posted
Study publicly available on registry
January 14, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedApril 21, 2020
April 1, 2020
5.7 years
January 12, 2014
April 20, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
freedom of cardiac device-related infection
check the symptoms of infection. If have symptoms of infection : check the fever, heart rate, respiration rate, blood test, EKG
1 year after precedure
Study Arms (2)
Hydrogen peroxide pretreatment group
ACTIVE COMPARATORHydrogen peroxide pretreatment perform before cardiac devices Implantation. It disinfects the cardiac devices pocket using Hydrogen peroxide gauze.
Control group
NO INTERVENTIONNo intervention group
Interventions
Hydrogen peroxide pretreatment perform before cardiac devices Implantation. It disinfects the cardiac devices pocket using Hydrogen peroxide gauze.
Eligibility Criteria
You may qualify if:
- scheduled for cardiac devices Implantation
You may not qualify if:
- under the age of 18
- Hydrogen peroxide allergy
- take an antibiotic
- History of infection within 30 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yong Seog Ohlead
Study Sites (1)
Seoul St Mary's Hospital
Seoul, Seo Ch-gu, 137-701, South Korea
MeSH Terms
Conditions
Study Officials
- STUDY CHAIR
Yong Seog Oh, Ph.D
Seoul St. Mary's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- ph.D
Study Record Dates
First Submitted
January 12, 2014
First Posted
January 14, 2014
Study Start
December 1, 2013
Primary Completion
August 1, 2019
Study Completion
October 1, 2019
Last Updated
April 21, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share